ga naar hoofdinhoud
Vademecum systeemtherapie Gynaecologische tumoren Literatuur en richtlijnen
Voorlezen

Literatuur

  1. Lurain JR et al. Single-agent methotrexate chemotherapy for the treatment of non-metastatic gestational trophoblast tumors. Am J Obstet Gynecol 1995; 172:574
  2. Covens A et al. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia. Cancer 2006; 107(6):1280-6
  3. McNeish IA et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002 Apr 1; 20(7):1838-44
  4. Chapman- Davis E et al. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecologic Oncology 2012; 125:572-575
  5. Bower M et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997; 15:2636
  6. Newlands ES et al. Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA / cyclophosphamide and vincristine chemotherapy and patients presenting with metastaic placental site trophoblastic tumors. J Clin Oncol 2000; 18:854
  7. Lok, C et al. Practical guidelines for the treatment of gestational trophoblastic disease: collaboration of the European organisation for the treatment of trophoblastic disease (EOTTD) - European society of gynaecologic oncology (ESGO) - Gynecologic cancer intergroup (GCIG) -International society for the study of trophoblastic diseases (ISSTD). J Clin Oncol 2025; 43:2119-2128
  8. Alifrangis C et al. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol 2013; 31:280-286
  9. Wang J et al. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel / cisplatin alternating with paclitaxel / etoposide (TP/TE) Ann Oncol 2008; 19:1578-1583
  10. El-Helw LM et al. High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia Br J Cancer 2005; 93:620-621

Richtlijnen

Ga naar de richtlijn Trofoblastziekten in de FMS richtlijnen­database.

Ga naar de richtlijn Gestational trophoblastic disease van de EOTDD, ESGO, GCIG en ISSTD.